Bafna Pharma. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2019	Jun-2019	Sep-2018	Jun-2018	--
Gross Sales	11.57	6.85	8.84	11.95	--
Excise Duty	--	--	--	--	--
Net Sales	11.57	6.85	8.84	11.95	--
Other Operating Income	--	--	--	--	--
Other Income	0.59	0.30	(0.03)	0.09	--
Total Income	12.16	7.15	8.80	12.04	--
Total Expenditure	11.94	9.72	8.65	13.77	--
PBIDT	0.22	(2.57)	0.15	(1.73)	--
Interest	0.04	0.13	0.62	0.83	--
PBDT	0.17	(2.69)	(0.47)	(2.56)	--
Depreciation	0.72	1.02	0.75	1	--
Minority Interest Before NP	--	--	--	--	--
Tax	--	--	--	--	--
Deferred Tax	0.04	(1.58)	0.05	(0.04)	--
Reported Profit After Tax	(0.59)	(2.13)	(1.28)	(3.52)	--
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	(0.59)	(2.13)	(1.28)	(3.52)	--
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	(0.59)	(2.13)	(1.28)	(3.52)	--
EPS (Unit Curr.)	(0.25)	(0.90)	(0.80)	--	--
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	23.66	23.66	23.66	23.66	--
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	1.90	(37.52)	1.70	(14.48)	--
PBDTM(%)	1.47	(39.27)	(5.32)	(21.42)	--
PATM(%)	(5.10)	(31.09)	(14.48)	(29.46)	--

QuickLinks for Bafna Pharmaceuticals Ltd.